Flavin coenzymes are ubiquitous in all organisms because of their involvements in central metabolic pathways. Plants and many microorganisms obtain the precursor riboflavin by biosynthesis, whereas animals depend on nutritional sources. Numerous pathogenic microorganisms are unable to takeup flavins from the environment and hence are absolutely dependent on their endogenous production. Therefore, the enzymes involved in riboflavin biosynthesis have the potential to become attractive candidates for the design of new defenses against antibiotic-resistant pathogens.
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During riboflavin biosynthesis, GTP cyclohydrolase II first catalyzes the hydrolytic C8 release of GTP to yield formate and pyrophosphate as side products. The product, 2, 5-diamino-6-ribosylamino-4(3H)-pyrimidinone 5'-phosphate (compound 1) is converted into 5-amino-6-ribitylamino-2,4 (1H, 3H)-pyrimidinedione 5'-phosphate (compound 4) by deamination of the pyrimidine ring and NAD(P)H-dependent reduction of the ribose (Fig. 1) . The deamination and reduction steps have been shown to proceed in the opposite order in yeast and E. coli. Most eubacteria contain a bifunctional protein; for instance the Bacillus subtilis RibG (BsRibG) is composed of an N-terminal deaminase domain (D domain) and a C-terminal reductase domain (R domain). In contrast, in fungi, plants and most archaea, these two enzymes are separate. To gain structural insights into the inhibitor design, substrate specificity and evolution, we have solved the BsRibG structure at 2.41-Å resolution.
Fusion of Two Enzyme Domains in RibG
Analytical ultracentrifugation experiments clearly demonstrated that BsRibG exists as a tetramer in solution as well as in crystal form, where the enzyme forms a tetrameric ring-like structure (Fig. 2) . Molecules A and B interact with each other through their D domains, while molecule A makes extensive contacts with molecule C through their R domains. There are no contacts between molecules A and D in the tetramer, and the D and R domains make only a few contacts. There is no evidence for any dependence of the active sites within the RibG tetramer. Previous deletion mutants have demonstrated that the N-terminal 147 residues and the C-terminal 248 residues of BsRibG were sufficient for their respective enzyme activities. However, these truncated proteins could not be isolated due to poor stability. Therefore, even though the two enzyme domains can fold independently, the domain fusion is crucial for the enzyme activities through formation of a stable tetrameric structure.
Structural Conservation and Divergence in the CDA Superfamily
The D domain belongs to the cytidine deaminase (CDA) superfamily, which consists of the mononucleotide deaminases involved in nucleotide metabolism, and the RNA(DNA)-editing deaminases involved in gene diversity and in anti-virus defense. These deaminases catalyze the hydrolytic deamination of cytosine, guanine, adenine moieties and several of their therapeutically useful analogues. Detailed structural comparisons reveal a common three-layered α/β/α structure with the five β-strands (β1-β5) and three helices (αA -αC) (Fig. 3(A) ). The active-site architecture of the D domain resembles those of the CDA members, which share a similar zinc-assisted deamination mechanism. The substrate was then modeled into the active site through superposition of the nucleobase rings because of the highly conserved interaction networks surrounding the target amino group.
In contrast, the C-terminal segment beyond the β4 strand, is quite diverse and may make a major contribution to the structural plasticity and functional diversity among the CDA members (Fig. 3(A) ). For instance, yeast cytosine deaminase (yCD) and the t-RNA specific adenosine deaminase from Aquifex aeolicus (AaTADA) unexpectedly superimpose very well, with a rmsd of 1.08 Å for 115 Cα atoms with 22% sequence identity. The major structural difference around the active-site cavity is the C-terminal helix. In yCD as well as Bacillus subtilis guanine deaminase (BsGD), genetic changes to alter the substrate specificity is through an introduction of substraterecognition residues at the C-terminal tail (Asp 155 in yCD and Tyr 156 in BsGD), which then forms a "flap"
capping and hence narrowing the opening of the active-site cavity upon substrate binding to limit the pocket size for the nucleobase. In contrast, the C-terminal tail in AaTADA as well as CDA, dCMP deaminase, and RibG, swings away to enlarge the activesite cavity for their larger substrates.
In combination with a sequence-structure analysis, a structure-based sequence alignment of the CDA members was constructed, which reveals unique member signatures useful for gene annotation and an optimal alignment for comparative modeling. To date, apolipoprotein B mRNA-editing catalytic subunit 1 (APOBEC1) and its sequence homologues, activation-induced deaminase (AID), APOBEC2 and the tandem repeats APOBEC3A to 3H, are the only identified C-to-U RNA (DNA)-editing deaminases in humans. AID is an essential B cell-specific factor required for antibody maturation, while several APOBECs are involved in defense against a broad range of retroviruses. We have modeled residues 1-160 of human AID into a CDA fold, which reveals the possible effects of the AID loss-of-function point mutants of AID in patients with hyper-IgM syndrome type 2.
Structural Conservation and Divergence between BsRibG and DHFRs
A structural homology search by DALI revealed that the R domain of BsRibG displays significant structural similarity to dihydrofolate reductase (DHFR) (Fig. 3(B) ). DHFR catalyzes the NADPH-utilizing reduction of DHF to tetrahydrofolate. The R-R structure of BsRibG is similar to the highly stable dimeric Thermotoga maritime DHFR (TmDHFR). Structural superposition of BsRibG and TmDHFR reveals a rmsd of 1.5 Å Biology 83 Fig. 3 : (A) Structural superposition of BsRibG (red), yCD (blue), T4-bacteriophage dCMP deaminase (green), and AaTADA (yellow). The zinc ion is displayed as a sphere (magenta) with the yCD inhibitor, 3,4-dihydrouracil (DHU) (cyan) as balland-stick representations. These deaminses share the conserved β-sheet and helices αA -αC, even a part of the αE helix. T4dCMPD contains a ~60-residue insertion, which folds into two helices (αB' and αB'') and flexible loops. The C-terminal tail of yCD folds backward to limit the pocket size, whereas those of the remaining members swing away to enlarge the active-site cavity. (B) Structural superposition of the R domain of BsRibG (red) and TmDHFR (green). The R domain contains an extra ~25-residue insertion, which folds into the αD' helix and the βD' strand.
for 120 Cα atoms with 25% sequence identity. The strong conservation of the tertiary structures suggests that these two reductases involved in the riboflavin and folate biosyntheses are descended from a single ancestral gene and thereby define a new superfamily.
The enzymatic mechanism of DHFR has been chemically and structurally studied in detail. Similarly, RibG is expected to catalyze the reduction of a cyclic ribosyl into an open ribityl group by hydride transfer from the C 4 atom of the nicotinamide ring of NAD(P)H to the C 278, 19111 (2003) .
Contact e-mail
shliaw@ym.edu.tw
